You're reading the free version. Trader adds the live tape and alerts.
Start tracking
AXSM Sale Disclosure
Jacobson Mark L. · SEC Form 4 · Filed Sep 3, 2026
Sale
Calculated transaction value
$2.09M
Jacobson Mark L. Chief Operating Officer
AXSM
Axsome Therapeutics
AXSM
Transaction date
Sep 3, 2026
Public filing date
Sep 3, 2026
Filing lag
Filed same day
AXSM daily price context
Close on/before transaction
$208.35
Sep 3, 2026
First close after public filing
$206.68
Sep 4, 2026
30-day return after filing
-14.32%
Through Oct 5, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 10,000 shares @ $208.65
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-382277
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$2.22M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Axsome Therapeutics, Inc. AXSM | Exercise | Sep 3, 2026 | $129.5K |
| Axsome Therapeutics, Inc. AXSM Current | Sale | Sep 3, 2026 | $2.09M |
| Axsome Therapeutics, Inc. AXSM | Exercise | Sep 3, 2026 | $0 |